Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview

Niagen Bioscience

05/05/2025 21:20

Niagen Bioscience Inc NAGE.OQ NAGE.O is expected to show a rise in quarterly revenue when it reports  results on May 7 for the period ending March 31 2025

The Los Angeles California-based  company is expected to report a 22.3% increase in revenue to $27.1 million from $22.15 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Niagen Bioscience Inc is for earnings of 2 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Niagen Bioscience Inc is $8.05​, above​ its last closing price of $8.00. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
0.02
0.02
0.09
Beat
350
Sep. 30 2024
0.01
0.00
0.02
Beat
500.6
Jun. 30 2024
-0.02
-0.02
0.00
Beat
100​
Mar. 31 2024
-0.02
-0.02
-0.01
Beat
40
​​Dec. 31 2023
-0.03
-0.03
0.00
Beat
100
Sep. 30 2023
-0.03
-0.03
-0.01
Beat
69.2​
Jun. 30 2023
-0.04
-0.04
-0.03
Beat
20
Mar. 31 2023
-0.05
-0.05
-0.03
Beat
37.5

This summary was machine generated May 5 at 20:20 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)